老年新诊断胶质母细胞瘤IMRT勾画与计划质量的预运行研究:JCOG1910
日本临床肿瘤学组JCOG1910研究在随机III期试验入组前开展预运行研究,41家机构对基准病例进行勾画和IMRT计划。6家机构因勾画偏差需修改;GTV的DSC为0.37±0.19,剂量体积标准40/41家达标。结论认为需给予反馈并定期共享信息。
要点
- 41家机构参与预运行研究,6家因勾画偏差需修改。
- GTV的DSC均值0.37±0.19,MDA均值9.41±3.99 mm。
- 40/41家机构满足剂量体积方案限值,1家处于可接受范围。
核心结论
- 部分机构勾画偏差需修改,需在后续前瞻性JCOG1910研究中给予适当反馈并定期共享信息。
研究设计与样本
- 日本临床肿瘤学组JCOG1910随机III期研究入组前开展的预运行研究,41家参与机构对1例基准病例报告GTV、CTV、PTV勾画及治疗计划。
- 参与机构分别制作A组(40.05 Gy/15次)和B组(25 Gy/5次)的IMRT治疗计划。
- 勾画偏差以DSC和MDA与研究室参考靶区比较评估,并评估各靶区及危及器官的剂量体积标准。
主要发现
- 6家机构因GTV勾画不足、CTV未考虑解剖屏障及违反方案修改PTV而未遵循方案,需修改。
- 与参考勾画相比,GTV的DSC均值±标准差为0.37±0.19、MDA为9.41±3.99 mm。
- CTV的DSC为0.80±0.08、MDA为4.31±1.85 mm;PTV的DSC为0.83±0.05、MDA为4.23±1.45 mm。
- 剂量体积标准方面,41家机构中40家满足方案限值,仅1家处于可接受范围。
关键数值与推荐
- A组放疗剂量为40.05 Gy/15次,B组为25 Gy/5次,均采用IMRT技术。
- GTV的DSC均值0.37±0.19、MDA 9.41±3.99 mm;CTV的DSC 0.80±0.08、MDA 4.31±1.85 mm;PTV的DSC 0.83±0.05、MDA 4.23±1.45 mm。
- 剂量体积标准:41家机构中40家满足方案限值,1家处于可接受范围。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A dummy run was conducted to ensure the quality of intensity-modulated radiotherapy (IMRT) before registration in a randomized phase III study of elderly patients with newly diagnosed glioblastoma by the Japan Clinical Oncology Group 1910 (JCOG1910). METHODS: All 41 institutions enrolled in this study were required to report outlining that included gross tumor volume (GTV), clinical target volume (CTV), planning target volume (PTV), and treatment planning for one benchmark case. First, deviations in outlining were evaluated using the Dice similarity coefficient (DSC) and mean distance agreement (MDA), compared to reference targets delineated by the research secretariat. Second, the participating institutions were required to create treatment plans for arms A (40.05 Gy in 15 fractions) and B (25 Gy in 5 fractions) using IMRT techniques. The quality of the outlining and dose-volume criteria for each target and organs at risk were evaluated. RESULTS: Six institutions failed to adhere to the protocol and required revision due to insufficient GTV outlining, not considering anatomical barriers for CTV, and modifying PTV against protocols. Compared to the reference outlining, the means and standard deviations of DSC and MDA were 0.37 ± 0.19 and 9.41 ± 3.99 mm for GTV; 0.80 ± 0.08 and 4.31 ± 1.85 mm for CTV; and 0.83 ± 0.05 and 4.23 ± 1.45 mm for PTV, respectively. Regarding dose-volume criteria, 40 of the 41 institutions met the per-protocol limits; only one was within the acceptable limits. CONCLUSIONS: Several institutions demonstrated deviations in outlining that necessitated revisions. Thus, appropriate feedback and periodic sharing of information with participating institutions is necessary in the upcoming prospective JCOG1910 study.
引用
- Ono T, Uto M, Mineharu Y, et al. Dummy run study for outlining and plan quality of intensity-modulated radiotherapy in elderly patients with newly diagnosed glioblastoma: The Japan clinical oncology group study JCOG1910 (AgedGlio-PIII). Radiat Oncol. 2025. PMID: 40059195. doi:10.1186/s13014-025-02612-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。